[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Subscription::
News& Events::
Contact us::
Site Facilities::
Ethics & Permissions::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Indexing
                        
..
:: Volume 8, Issue 2 (Summer 2011) ::
Sci J Iran Blood Transfus Organ 2011, 8(2): 115-121 Back to browse issues page
Characteristics of CoolClot, the invented novel hemostatic agent
S.M.J. Mortazavi , M. Atefi , P. Roshan-shomal , N. Tanide , N. Raadpey , Z. Bagheri
Abstract:   (18368 Views)

  Abstract

 Background and Objectives

 Uncontrolled bleeding is the first leading cause of preventable death in the battlefield and the second cause of mortality in civil accidents. Incompressible hemorrhage control is among the interventions that drastically increase the survival rate of the wounded individuals.

 

 Materials and Methods

 Three healthy hybrid dogs were selected and after induction of anesthesia with Ether, either arterial puncture by a needle or arteriotomy was performed on both groin regions of the dogs . For control arteries, only a 4 min pressure using a sterile gauze was performed, while for the femoral arteries of the opposite side, Cool Clot hemostatic agent was topically used before the pressure. To assess the Coagulation Time (CT), blood samples were collected from 10 volunteer students. CT was measured by a chronometer according to standard Lee -White method.

 

 Results

 In dog animal model, the Bleeding Time (BT) in control arteries (no hemostatic agent) was more than 15 minutes, while in case of the opposite sides which were treated with Cool Clot hemostatic agent, the BT was only up to 5 minutes. In the human phase of the study, the mean coagulation time in control blood samples was 253.4 ± 4.1 sec, while for blood samples treated with bentonite, zeolite and Cool Clot the mean times were 149.5 ± 50.0 , 162.3 ± 74.5 and 143.4 ± 114.6 sec, respectively.

 

 Conclusions

 The results obtained in this study indicate the significant efficacy of Cool Clot in shortening the BT in dog model or CT in human blood samples.

 

Keywords: Hemorrhage, Hemostases, Bentonite, Zeolites
Full-Text [PDF 310 kb]   (4529 Downloads)    
Type of Study: Research | Subject: Hematology
Published: 2013/08/28
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mortazavi S, Atefi M, Roshan-shomal P, Tanide N, Raadpey N, Bagheri Z. Characteristics of CoolClot, the invented novel hemostatic agent . Sci J Iran Blood Transfus Organ 2011; 8 (2) :115-121
URL: http://bloodjournal.ir/article-1-485-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 8, Issue 2 (Summer 2011) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.05 seconds with 39 queries by YEKTAWEB 4645